It sounds to me like maybe pre-clinical or on petri dish or mice since there is no mention of trial or phase 1.
Maybe phase 1 AFTER Vaxinia has been approved for at least 1 type of cancer ie Bile Duct AND Azel Cel has been approved for Blood cancers.
The schedule for trials seem to be quite full for 2024/2025 to be opening another trial programme. Imho. At least maybe in H2 2025 if preclinicals passed mustard. Imho
The top priority should be revenue or partnership(s) at this stage imho.
FIC or BIC could be eroded by time.
I could be reading it completely wrong.
It sounds to me like maybe pre-clinical or on petri dish or mice...
-
- There are more pages in this discussion • 5,215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $1.042M | 18.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628179 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 897037 | 6 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |